Sanofi Aventis

Aubagio-denopsy

"Aubagio" contains Drug / Molecule called "Teriflunomide". Aubagio is the active metabolite of the parent drug, leflunomide, which is use in the treatment of rheumatoid arthritis (RA). Leflunomide is rapidly converted almost entirely into Aubagio following oral ingestion and thus Aubagio has become the focus of development for use in patients with Multiple sclerosis.

“Denopsy” is the generic version of “Aubagio” and both contains same drug “ Teriflunomide”.

Details
Specification

Indication

Augagio is used in the treatment of Multiple sclerosis.

Note

Precaution

Aubagio is a prescription drug and should be used under proper medical guidance and advice.

Updated On Nov 02, 2019 by Admin

Strength

7 mg, 14 mg

Packing

1 X 28 Tablets (Strip)

Storage

Store below 30°C (86°F)

Was this page helpful?

☆ ☆ ☆ ☆ ☆

Not Upto Date Insufficient Helpful

Any suggestions or inputs for Shubhampharma.

Aubagio-denopsy also available as

NATCO PHARMA LIMITED (INDIA)

Denopsy

DENOPSY contains Drug / Molecule called “TERIFLUNOMIDE”. Teriflunomide is the active metabolite of the parent drug, leflunomide, which is used in the treatment of rheumatoid arthritis (RA). Leflunomide is rapidly converted almost entirely into teriflunomide following oral ingestion and thus teriflunomide has become the focus of development for use in patients with Multiple sclerosis.